Ligand validation:6AT4

THJ: THIOSULFATE

THJ is a Ligand Of Interest in 6AT4 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6AT4_THJ_A_801	99%	43%	0.063	0.995	1.73	0.5	-	-	0	0	100%	1
6AT4_THJ_A_802	96%	27%	0.079	0.987	1.95	1.04	-	-	0	0	100%	0.84
6AT4_THJ_B_601	95%	24%	0.071	0.973	2.1	1.07	1	-	0	0	100%	0.82
6AT4_THJ_A_803	79%	27%	0.094	0.938	2.36	0.65	1	-	0	0	100%	0.68
6AT4_THJ_B_602	60%	34%	0.121	0.907	1.63	1	-	-	0	0	100%	0.6
6AT2_THJ_A_705	99%	34%	0.059	0.987	2.05	0.59	1	-	0	0	100%	0.79
6AT3_THJ_A_602	96%	48%	0.075	0.982	1.51	0.54	-	-	0	0	100%	0.976
6ASM_THJ_A_706	89%	24%	0.089	0.968	2.41	0.75	1	-	0	0	100%	0.68
1JEC_THJ_A_540	94%	72%	0.09	0.991	0.96	0.14	-	-	0	0	100%	1
4XEZ_THJ_A_503	94%	37%	0.093	0.994	1.83	0.69	-	-	1	0	100%	0.3

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.